Subgroup analysis Results of subgroup analyses showed that patients who had received ICS without other long-acting bronchodilators (LABA or LABA/LAMA) had a trend of higher likelihood for SARS-COV-2 infection diagnosis, however, the risk did not reach statistical significance (pooled OR=1.408; 95% CI=0.693–2.858; p = 0.344) ( Fig. 4 A).
← all excerpts
The association between inhaled corticosteroid and the risks of SARS-COV-2 infection: A systematic review and meta-analysis.
1
0.3440
0.3440